A US eye specialist says he has developed a nutrient-based surgical procedure that offers 99% success in the treatment of keratoconus, an often devastating condition that can lead to blindness.
Brian Boxer Wachler, a world-renowned surgeon and the director of an eye-care center in Beverly Hills, California, says that C3-R (corneal collagen cross-linking with riboflavin) is the first vision correction procedure to use vitamin treatments for the disorder.
A single treatment of C3-R completely halts the disease in its tracks in 99% of cases, according to studies done by Dr Boxer Wachler and other doctors in Europe. The recovery time is only one day, and patients can normally resume 100% of their usual activities by the next day. After five years of study, there have been no side effects reported from this non-invasive procedure, he noted.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze